Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close
News & Events »
Tillotts Pharma AG opens new affiliate in Italy

Press Release

Tillotts Pharma AG opens new affiliate in Italy

Tillotts Pharma opens Italian establishment as a next important step in the expansion [...] Read more »
Tillotts Pharma AG announces launch of Asacol® 800mg Tablets in the People’s Republic of China

Press Release

Tillotts Pharma AG announces launch of Asacol® 800mg Tablets in the People’s Republic of China

RHEINFELDEN, Switzerland, 28.07.2021 - Tillotts Pharma AG (“Tillotts”), part of the Ja[...] Read more »
Tillotts Pharma AG announces a new sales organisation for its products in Switzerland

Press Release

Tillotts Pharma AG announces a new sales organisation for its products in Switzerland

The new establishment is part of Tillotts ambitious expansion plans throughout Europe [...] Read more »
Tillotts Pharma AG continues growth with launch in Belgium, the Netherlands and Luxembourg

Press Release

Tillotts Pharma AG continues growth with launch in Belgium, the Netherlands and Luxembourg

Tillotts Pharma AG strengthens its network in Europe by entering in Benelux market, wh[...] Read more »
Tillotts Pharma AG announces launch of Asacol<sup>TM</sup> 1G suppositories for treatment of ulcerative proctitis

Press Release

Tillotts Pharma AG announces launch of AsacolTM 1G suppositories for treatment of ulcerative proctitis

This new medication supports Tillotts strong gastroenterology portfolio and further st[...] Read more »
Tillotts Pharma AG under Agreement to Acquire Rights for DIFICLIR<sup>TM</sup> (fidaxomicin) from Astellas Pharma Europe Ltd.

Press Release

Tillotts Pharma AG under Agreement to Acquire Rights for DIFICLIRTM (fidaxomicin) from Astellas Pharma Europe Ltd.

Tillotts Pharma AG has acquired the rights to DIFICLIRTM (fidaxomicin) from Astellas P[...] Read more »
1 2 3 4 8